Citadel Advisors
RXL icon

Citadel Advisors’s ProShares Ultra Health Care RXL Stock Holding History

Citadel Advisors’s Portfolio RXL Stock Details RXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$377K Buy
8,231
+521
+7% +$26.6K ﹤0.01% 9940
2025
Q4 		$399K Buy
7,710
+442
+6% +$21.6K ﹤0.01% 9541
2025
Q3 		$309K Sell
7,268
-1,991
-22% -$80.6K ﹤0.01% 10300
2025
Q2 		$376K Buy
9,259
+1,256
+16% +$51.7K ﹤0.01% 9291
2025
Q1 		$389K Buy
8,003
+3,247
+68% +$158K ﹤0.01% 9027
2024
Q4 		$209K Sell
4,756
-2,766
-37% -$139K ﹤0.01% 10376
2024
Q3 		$421K Buy
+7,522
New +$410K ﹤0.01% 8633
2024
Q2 		– Sell
-8,210
Closed -$436K – 15241
2024
Q1 		$436K Buy
+8,210
New +$412K ﹤0.01% 8683
2023
Q4 		– Sell
-17,020
Closed -$703K – 15107
2023
Q3 		$703K Buy
17,020
+6,244
+58% +$275K ﹤0.01% 7328
2023
Q2 		$480K Sell
10,776
-16,096
-60% -$708K ﹤0.01% 8028
2023
Q1 		$1.15M Buy
26,872
+6,356
+31% +$278K ﹤0.01% 6472
2022
Q4 		$970K Sell
20,516
-19,014
-48% -$861K ﹤0.01% 6874
2022
Q3 		$1.52M Buy
39,530
+17,802
+82% +$785K ﹤0.01% 6130
2022
Q2 		$948K Buy
+21,728
New +$998K ﹤0.01% 7139
2021
Q4 		– Sell
-31,288
Closed -$1.49M – 14628
2021
Q3 		$1.49M Buy
31,288
+21,064
+206% +$1.07M ﹤0.01% 7103
2021
Q2 		$477K Sell
10,224
-44,712
-81% -$1.96M ﹤0.01% 10161
2021
Q1 		$2.19M Buy
54,936
+14,688
+36% +$580K ﹤0.01% 6178
2020
Q4 		$1.52M Sell
40,248
-73,820
-65% -$2.58M ﹤0.01% 5941
2020
Q3 		$3.73M Buy
114,068
+68,144
+148% +$2.19M ﹤0.01% 3595
2020
Q2 		$1.35M Buy
45,924
+1,120
+2% +$31.6K ﹤0.01% 5281
2020
Q1 		$1.02M Buy
44,804
+5,352
+14% +$154K ﹤0.01% 5311
2019
Q4 		$1.25M Sell
39,452
-6,392
-14% -$179K ﹤0.01% 5195
2019
Q3 		$1.13M Buy
45,844
+4,680
+11% +$119K ﹤0.01% 5395
2019
Q2 		$1.08M Buy
41,164
+4,528
+12% +$112K ﹤0.01% 5573
2019
Q1 		$957K Buy
36,636
+8,876
+32% +$224K ﹤0.01% 5668
2018
Q4 		$631K Buy
+27,760
New +$713K ﹤0.01% 6042
2017
Q1 		– Sell
-17,656
Closed -$265K – 7951
2016
Q4 		$265K Buy
17,656
+712
+4% +$10.8K ﹤0.01% 5854
2016
Q3 		$279K Buy
+16,944
New +$286K ﹤0.01% 5793
2016
Q2 		– Sell
-14,720
Closed -$211K – 7321
2016
Q1 		$211K Sell
14,720
-2,640
-15% -$36.8K ﹤0.01% 5572
2015
Q4 		$286K Sell
17,360
-22,832
-57% -$366K ﹤0.01% 5285
2015
Q3 		$573K Buy
40,192
+29,056
+261% +$517K ﹤0.01% 4614
2015
Q2 		$207K Buy
+11,136
New +$203K ﹤0.01% 6274
2014
Q2 		– Sell
-22,384
Closed -$252K – 8255
2014
Q1 		$252K Buy
+22,384
New +$247K ﹤0.01% 5240

Other funds holding RXL

IMC Chicago
IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return
HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return

Citadel Advisors's RXL Position: Q1 2026 in Review

Citadel Advisors increased its ProShares Ultra Health Care (RXL) stake by 6.8% in Q1 2026, buying an estimated $26.6K and bringing the position to 8,231 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #9940.

Citadel Advisors first reported a position in RXL in Q1 2014 and has held it in 33 quarters since. The position peaked at $3.73M in Q3 2020. 17 funds tracked by Wall St. Rank hold RXL as of Q1 2026.

  • Citadel Advisors held 8,231 shares of ProShares Ultra Health Care worth $377K as of Q1 2026.
  • Citadel Advisors bought 521 ProShares Ultra Health Care shares in Q1 2026, an estimated $26.6K.
  • ProShares Ultra Health Care made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9940 holding.
  • Citadel Advisors first reported a position in ProShares Ultra Health Care in Q1 2014 and has held it in 33 quarters since.
  • Citadel Advisors's ProShares Ultra Health Care position peaked at $3.73M in Q3 2020.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.